|
1
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar
|
|
2
|
Ahmed AA, Zia H and Wagner L: Therapy
resistance mechanisms in Ewing's sarcoma family tumors. Cancer
Chemother Pharmacol. 73:657–663. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Constantinidou A, Pollack S, Loggers E,
Rodler E and Jones RL: The evolution of systemic therapy in
sarcoma. Expert Rev Anticancer Ther. 13:211–223. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miao J, Wu S, Peng Z, Tania M and Zhang C:
MicroRNAs in osteosarcoma: Diagnostic and therapeutic aspects.
Tumour Biol. 34:2093–2098. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun K and Lai EC: Adult-specific functions
of animal microRNAs. Nat Rev Genet. 14:535–548. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xiong Y, Zhang L and Kebebew E: MiR-20a is
upregulated in anaplastic thyroid cancer and targets LIMK1. PLoS
One. 9:e961032014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao S, Yao D, Chen J and Ding N:
Circulating miRNA-20a and miRNA-203 for screening lymph node
metastasis in early stage cervical cancer. Genet Test Mol
Biomarkers. 17:631–636. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chang Y, Liu C, Yang J, Liu G, Feng F,
Tang J, Hu L, Li L, Jiang F, Chen C, et al: MiR-20a triggers
metastasis of gallbladder carcinoma. J Hepatol. 59:518–527. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Joseph LJ, Le Beau MM, Jamieson GA Jr,
Acharya S, Shows TB, Rowley JD and Sukhatme VP: Molecular cloning,
sequencing, and mapping of EGR2, a human early growth response gene
encoding a protein with “zinc-binding finger” structure. Proc Natl
Acad Sci USA. 85:7164–7168. 1988. View Article : Google Scholar
|
|
12
|
Li X, Zhang Z, Yu M, Li L, Du G, Xiao W
and Yang H: Involvement of miR-20a in promoting gastric cancer
progression by targeting early growth response 2 (EGR2). Int J Mol
Sci. 14:16226–16239. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sumitomo S, Fujio K, Okamura T and
Yamamoto K: Egr2 and Egr3 are the unique regulators for systemic
autoimmunity. JAK-STAT. 2:e239522013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu Z, Wang C, Wang M, Li Z, Casimiro MC,
Liu M, Wu K, Whittle J, Ju X, Hyslop T, et al: A cyclin D1/microRNA
17/20 regulatory feedback loop in control of breast cancer cell
proliferation. J Cell Biol. 182:509–517. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Z, Liu M, Zhu H, Zhang W, He S, Hu C,
Quan L, Bai J and Xu N: Suppression of p21 by c-Myc through members
of miR-17 family at the post-transcriptional level. Int J Oncol.
37:1315–1321. 2010.PubMed/NCBI
|
|
16
|
Arabi L, Gsponer JR, Smida J, Nathrath M,
Perrina V, Jundt G, Ruiz C, Quagliata L and Baumhoer D:
Upregulation of the miR-17-92 cluster and its two paraloga in
osteosarcoma - reasons and consequences. Genes Cancer. 5:56–63.
2014.PubMed/NCBI
|
|
17
|
Tian Q, Jia J, Ling S, Liu Y, Yang S and
Shao Z: A causal role for circulating miR-34b in osteosarcoma. Eur
J Surg Oncol. 40:67–72. 2014. View Article : Google Scholar
|
|
18
|
Xu JQ, Liu P, Si MJ and Ding XY:
MicroRNA-126 inhibits osteosarcoma cells proliferation by targeting
Sirt1. Tumour Biol. 34:3871–3877. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cao ZQ, Shen Z and Huang WY: MicroRNA-802
promotes osteosarcoma cell proliferation by targeting p27. Asian
Pac J Cancer Prev. 14:7081–7084. 2013. View Article : Google Scholar
|
|
20
|
Tang M, Lin L, Cai H, Tang J and Zhou Z:
MicroRNA-145 downregulation associates with advanced tumor
progression and poor prognosis in patients suffering osteosarcoma.
Onco Targets Ther. 6:833–838. 2013.PubMed/NCBI
|
|
21
|
van Kouwenhove M, Kedde M and Agami R:
MicroRNA regulation by RNA-binding proteins and its implications
for cancer. Nat Rev Cancer. 11:644–656. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Unoki M and Nakamura Y: Growth-suppressive
effects of BPOZ and EGR2, two genes involved in the PTEN signaling
pathway. Oncogene. 20:4457–4465. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Baldin V, Lukas J, Marcote MJ, Pagano M
and Draetta G: Cyclin D1 is a nuclear protein required for cell
cycle progression in G1. Genes Dev. 7:812–821. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Masamha CP and Benbrook DM: Cyclin D1
degradation is sufficient to induce G1 cell cycle arrest despite
constitutive expression of cyclin E2 in ovarian cancer cells.
Cancer Res. 69:6565–6572. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang M, Zhong J, Zhao M, Wang J, Gu Y,
Yuan X, Sang J and Huang C: Overexpression of nuclear
apoptosis-inducing factor 1 altered the proteomic profile of human
gastric cancer cell MKN45 and induced cell cycle arrest at G1/S
phase. PLoS One. 9:e1002162014. View Article : Google Scholar : PubMed/NCBI
|
